Generex Biotechnology Corporation (GNBTQ) Stock Analysis
DELISTED
What happened to Generex Biotechnology Corporation (GNBTQ) stock?
Generex Biotechnology Corporation (GNBTQ) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Generex Biotechnology Corporation (GNBTQ). Generex Biotechnology Corporation focuses on developing and administering large molecule drugs through oral delivery and point-of-care diagnostics. The company is currently undergoing Chapter 7 liquidation proceedings.
Last analyzed: Mar 16, 2026Generex Biotechnology Corporation (GNBTQ) Healthcare & Pipeline Overview
GNBTQ OTC Market Information
GNBTQ trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy GNBTQ shares?
No. GNBTQ stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for GNBTQ elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before GNBTQ stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Generex Biotechnology Corporation. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.